FOXO TECHNOLOGIES INC. (FOXO) Current Ratio
- Current ratio · latest quarter: Value 0.12×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.12× | Current assets / current liabilities. $4.76M ÷ $40.62M ≈ 0.12× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.76M USD | Assets, Current |
| Current obligations | 40.62M USD | Liabilities, Current |
| Cash and equivalents | 58.41K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 4.14M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 160.47K USD | Inventory, Net |
| Payables | 7.81M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.76M | $40.62M | $58.41K | (m) | $4.14M | $160.47K | $7.81M | (m) | 0.12× |
| 2026-03-31 | $4.49M | $31.56M | $65.90K | (m) | $3.91M | $188.56K | $7.48M | (m) | 0.14× |
| 2025-12-31 | $3.11M | $28.66M | $207.45K | (m) | $2.47M | $183.63K | $6.97M | (m) | 0.11× |
| 2025-09-30 | $4.17M | $28.64M | $628.56K | (m) | $3.16M | $7.75K | $6.76M | (m) | 0.15× |
| 2025-06-30 | $5.63M | $32.90M | $321.79K | (m) | $4.92M | (m) | $7.03M | (m) | 0.17× |
| 2025-03-31 | $3.19M | $33.79M | $16.91K | (m) | $2.65M | (m) | $7.32M | (m) | 0.09× |
| 2024-12-31 | $2.88M | $31.20M | $68.27K | (m) | $2.27M | $161.47K | $6.68M | (m) | 0.09× |
| 2024-09-30 | $2.91M | $34.35M | $34.00K | (m) | $2.00M | (m) | $8.20M | (m) | 0.08× |
| 2024-06-30 | $489.00K | $21.31M | $33.00K | (m) | $276.00K | (m) | $5.31M | (m) | 0.02× |
| 2024-03-31 | $262.00K | $17.07M | $3.00K | (m) | (m) | (m) | $4.99M | (m) | 0.02× |
| 2023-12-31 | $233.73K | $14.34M | $38.12K | (m) | (m) | (m) | $4.56M | (m) | 0.02× |
| 2023-09-30 | $2.58M | $13.52M | $42.00K | (m) | (m) | (m) | $4.82M | (m) | 0.19× |
| 2023-06-30 | $3.33M | $10.16M | $215.00K | (m) | (m) | (m) | $4.02M | (m) | 0.33× |
| 2023-03-31 | $6.28M | $8.59M | $2.15M | (m) | (m) | $1.30M | $2.98M | (m) | 0.73× |
| 2022-12-31 | $12.30M | $6.91M | $5.51M | (m) | (m) | (m) | $3.47M | (m) | 1.78× |
| 2022-09-30 | $17.80M | $33.01M | $10.45M | (m) | (m) | $2.06M | $2.71M | (m) | 0.54× |
| 2022-06-30 | $273.09K | $3.53M | (m) | (m) | (m) | (m) | $2.58M | (m) | 0.08× |
| 2022-03-31 | $350.15K | $2.19M | $193.33K | (m) | (m) | (m) | $1.99M | (m) | 0.16× |
| 2021-12-31 | $7.62M | $36.06M | $6.86M | (m) | (m) | $295.00K | $3.46M | (m) | 0.21× |
| 2021-09-30 | $1.25M | $164.10K | $1.01M | (m) | (m) | (m) | $159.10K | (m) | 7.59× |
| 2021-06-30 | $1.48M | $40.42K | $1.16M | (m) | (m) | (m) | $35.42K | (m) | 36.73× |
| 2021-03-31 | $1.71M | $63.20K | $1.30M | (m) | (m) | (m) | $58.20K | (m) | 27.06× |
| 2020-12-31 | $1.89M | $141.13K | $1.42M | (m) | (m) | (m) | $23.38K | (m) | 13.39× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |